Healthy Skepticism Library item: 13563

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Rowland D, Cooper S, Macias L.
Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation.
Int J Impot Res. 2008 Mar-Apr; 20:(2):115-20
http://www.nature.com/ijir/journal/v20/n2/abs/3901559a.html;jsessionid=1A7DA59E195B52F462F4B4C84D67AA9F

Abstract:

For many men, the treatment of sexual dysfunctions such as premature ejaculation may well be most effective when pharmacotherapy is combined with psychotherapy. Yet the essential elements of psychotherapy that might best be combined with pharmacological-based therapy are currently unknown. Support for evidence-based studies that identify key components of psychotherapy that might improve positive long-term outcomes, including patient satisfaction, are needed. Pharmaceutical companies having a vested interest in achieving both treatment adherence and improved patient outcomes could benefit from such information.

Keywords:
Drug Industry/economics* Ejaculation Evidence-Based Medicine Humans Male Psychotherapy* Research Research Support as Topic Sexual Dysfunction, Physiological/therapy* Sexual Dysfunctions, Psychological/therapy*